Seth van Voorhees - 13 Jun 2022 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chief Financial Officer
Signature
/s/ Seth VanVoorhees
Issuer symbol
NRXP
Transactions as of
13 Jun 2022
Net transactions value
$0
Form type
3
Filing time
29 Jun 2022, 18:14:04 UTC
Previous filing
17 Jun 2021
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NRXP Employee Stock Option Plan (right to Buy) 13 Jun 2022 Common Stock, par value $0.001 per share 162,500 $0.5140 Direct
holding NRXP Employee Stock Option Plan (right to Buy) 13 Jun 2022 Common Stock, par value $0.001 per share 162,500 $0.5140 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.